Emc Capital Management Alkermes Plc. Transaction History
Emc Capital Management
- $185 Million
- Q2 2025
A detailed history of Emc Capital Management transactions in Alkermes Plc. stock. As of the latest transaction made, Emc Capital Management holds 2,428 shares of ALKS stock, worth $75,413. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,428Holding current value
$75,413% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$904 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$575 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$312 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$255 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$199 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.1B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...